Dr. David Swee was recently installed as the 232nd president of the Medical Society of New Jersey during the House of Delegates session of the organization’s 2024 Annual Meeting on April 20.
He will assume the presidency from Dr. Donald Chervenak.
Swee has been a member of MSNJ since 1979 and member of MSNJ’s board of trustees since 2017, having served on various councils and committees.
“Dr. Swee is a passionate advocate for patient health, a supportive colleague and a dedicated physician,” Larry Downs, CEO of MSNJ, said. “With a keen eye toward issues of health equity and a focus on primary care, he will bring new ideas and fresh perspective to our organization. I welcome Dr. Swee as our new president for the 2024-2025 term and look forward to his continued leadership and advocacy on behalf of MSNJ members and all New Jersey physicians.”
Swee shared his priorities for the year in his inaugural speech: the ongoing fight over prior authorization; the need to improve payment for all physicians; and the idea of exploring a new structure for MSNJ’s House of Delegates.
Swee is emeritus professor and immediate past chair of the Rutgers Robert Wood Johnson Medical School Department of Family Medicine and Community Health. He served as an associate dean for faculty affairs at RWJMS from 2011 to 2019.
Swee has held numerous external positions, including serving on the American Medical Association Council on Medical Education, which he chaired; on the Liaison Committee on Medical Education, which accredits medical schools; on the Accreditation Council for Continuing Medical Education’s Accreditation Review Committee; and on the Medical Society of New Jersey Committee on Medical Education, which he chaired for many years.
Clinically related positions have included being chair, MSNJ Council on Medical Services; serving as the MSNJ representative to the Physician Consortium on Performance Improvement; and being a past chair of the AMA Advisory Committee on Group Practice Physicians. In the area of health policy leadership, he has served as an MSNJ delegate to the AMA since 2014 and as chair of the New Jersey Drug Utilization Review Board since 1998.
